BeneChill is a pioneering company specializing in non-invasive cooling innovations to enhance patient recovery after critical ischemic events. Founded in 2004 and based in San Diego, California, the company focuses on the development of non-invasive cooling technologies aimed at improving patient outcomes following acute ischemic events such as cardiac arrest, stroke, and traumatic brain injury. The RhinoChill System, one of the company's key innovations, is designed to lower patient temperatures. With its last $6.57M Venture Round investment on 20 February 2013, BeneChill operates in both the United States and Europe. As a medical device company, it operates in the industries of Health Care, Industrial, and Medical Devices.
No recent news or press coverage available for BeneChill.